Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sio Gene Thera0 Inc. (AXON) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sio Gene Thera0 Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1636050.
Total stock buying since 2016: $412,553,391.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $70,122.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 100,000 | $248,200 | 0 | $0 | 0 | $0 |
| 2020 | 5,400,833 | $20,171,165 | 0 | $0 | 0 | $0 |
| 2019 | 60,010,873 | $90,056,669 | 0 | $0 | 0 | $0 |
| 2018 | 204,310,712 | $290,051,741 | 0 | $0 | 0 | $0 |
| 2017 | 647,249 | $11,999,994 | 0 | $0 | 77,914 | $70,122 |
| 2016 | 2,300 | $25,622 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-03 | 100,000 | $248,200 | 0 | $0 | 0 | $0 |
| 2020-11 | 10,000 | $23,400 | 0 | $0 | 0 | $0 |
| 2020-07 | 47,500 | $129,927 | 0 | $0 | 0 | $0 |
| 2020-03 | 10,000 | $17,840 | 0 | $0 | 0 | $0 |
| 2020-02 | 5,333,333 | $19,999,998 | 0 | $0 | 0 | $0 |
| 2019-06 | 10,870 | $56,669 | 0 | $0 | 0 | $0 |
| 2019-03 | 60,000,003 | $90,000,000 | 0 | $0 | 0 | $0 |
| 2018-12 | 90,000,000 | $90,000,000 | 0 | $0 | 0 | $0 |
| 2018-08 | 25,000 | $51,749 | 0 | $0 | 0 | $0 |
| 2018-06 | 114,285,712 | $199,999,992 | 0 | $0 | 0 | $0 |
| 2017-12 | 0 | $0 | 0 | $0 | 77,914 | $70,122 |
| 2017-04 | 647,249 | $11,999,994 | 0 | $0 | 0 | $0 |
| 2016-03 | 2,300 | $25,622 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-23 | Cheruvu Pavan (Chief Executive Officer) | Buy | 100,000 | 2.48 | 248,200 |
| 2020-11-24 | Pande Atul | Buy | 10,000 | 2.34 | 23,400 |
| 2020-07-08 | Cheruvu Pavan (Principal Executive Officer) | Buy | 37,500 | 2.74 | 102,637 |
| 2020-07-08 | Pande Atul (Director) | Buy | 10,000 | 2.73 | 27,290 |
| 2020-03-16 | Pande Atul (Director) | Buy | 10,000 | 1.78 | 17,840 |
| 2020-02-24 | Roivant Sciences Ltd. (10% Owner) | Buy | 5,333,333 | 3.75 | 19,999,998 |
| 2019-06-14 | Cheruvu Pavan (Chief Executive Officer) | Buy | 7,500 | 5.21 | 39,075 |
| 2019-06-14 | Pande Atul (Director) | Buy | 3,370 | 5.22 | 17,594 |
| 2019-03-18 | Qvt Financial Investment Cayman Ltd. (10% Owner) | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2019-03-18 | Svf Holdings (uk) Llp (10% Owner) | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2019-03-18 | Shabet Rose Sharon | Buy | 13,333,334 | 1.50 | 20,000,000 |
| 2019-03-18 | Lo Andrew (10% Owner) | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2019-03-18 | Oren Dan | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2019-03-18 | Roivant Sciences Ltd. (10% Owner) | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2019-03-18 | Machado Patrick (10% Owner) | Buy | 6,666,667 | 1.50 | 10,000,000 |
| 2018-12-18 | Svf Holdings (uk) Llp (10% Owner) | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-12-18 | Shabet Rose Sharon | Buy | 20,000,000 | 1.00 | 20,000,000 |
| 2018-12-18 | Lo Andrew (10% Owner) | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-12-18 | Oren Dan | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-12-18 | Roivant Sciences Ltd. (10% Owner) | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-12-18 | Machado Patrick (10% Owner) | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-12-18 | Qvt Offshore Ltd. (10% Owner) | Buy | 10,000,000 | 1.00 | 10,000,000 |
| 2018-08-09 | Bickerstaff George (Director) | Buy | 25,000 | 2.07 | 51,749 |
| 2018-06-05 | Shabet Rose Sharon | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Softbank Vision Fund L.p. (10% Owner) | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Lo Andrew (10% Owner) | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Oren Dan | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Roivant Sciences Ltd. (10% Owner) | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Viking Long Fund Gp Llc | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Qvt Fund V Lp (10% Owner) | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2018-06-05 | Machado Patrick (10% Owner) | Buy | 14,285,714 | 1.75 | 24,999,999 |
| 2017-12-29 | Modig Berndt (Director) | Option Ex | 77,914 | .90 | 70,122 |
| 2017-04-17 | Vernon W Anthony (Director) | Buy | 53,937 | 18.54 | 999,991 |
| 2017-04-17 | Hung David (Principal Executive Officer) | Buy | 539,375 | 18.54 | 10,000,012 |
| 2017-04-17 | Falberg Kathryn E (Director) | Buy | 53,937 | 18.54 | 999,991 |
| 2016-03-10 | Altmeyer Mark (Pres&Chief Commercial Officer) | Buy | 2,300 | 11.14 | 25,622 |
Insider trading activities including stock purchases, stock sales, and option exercises of AXON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sio Gene Thera0 Inc. (symbol AXON, CIK number 1636050) see the Securities and Exchange Commission (SEC) website.